Triptodur® (triptorelin) for extended release injectable suspension is an FDA approved medication distributed in the US by Arbor Pharmaceuticals. Arbor Pharmaceuticals, a wholly-owned subsidiary of Azurity Pharmaceuticals, Inc., headquartered in Atlanta, Georgia, is a specialty pharmaceutical company that currently markets over twenty NDA or ANDA approved products, and also has several additional products in late-stage development. For more information regarding Triptodur (triptorelin) for extended release injectable suspension, visit www.triptodur.com/hcp or send email inquiries to email@example.com
Triptodur is manufactured by Debiopharm Research & Manufacturing SA on behalf of Arbor Pharmaceuticals, LLC. Triptodur is a registered trademark of Debiopharm International SA.